Results 81 to 90 of about 194,150 (247)
Current Approaches to Support Patients to Withdraw From Image and Performance Enhancing Drugs
Clinical Endocrinology, EarlyView.ABSTRACT Image and performance‐enhancing drugs (IPEDs) include agents such as androgens, growth hormone, and erythropoietin, which are used to enhance appearance and physical performance. Androgens, also known as anabolic‐androgenic steroids (AAS), are the most used IPEDs worldwide.
Elizabeth Hyams +3 more
wiley +1 more source
Clinical development of the GnRH agonist leuprolide acetate depot
, 2023 Leuprolide acetate is the first GnRH agonist that entered clinical development after the discovery of the native GnRH. Several long-acting depot formulations of leuprolide acetate (ranging from 1-month to 6-month intramuscular injections) have been ...
Kristof Chwalisz, M.D., Ph.D.
core +1 more source
Equine Veterinary Education, EarlyView.Summary Mittelschmerz is a well‐recognised benign peri‐ovulatory pain syndrome in women and, by physiological analogy, may also occur in mares. In equine practice, peri‐ovulatory ovarian pain has been associated with transient discomfort, colic‐like signs and behavioural changes, although its true clinical relevance remains poorly defined.
G. Marino +4 more
wiley +1 more source
Comparison of Controlled Ovarian Stimulation Protocols on IVF Outcome in Normal and Poor Responders
Gynecology Obstetrics & Reproductive Medicine, 2013 OBJECTIVE: Aim of this study is determining the influence of luteal long GnRH agonist and GnRH antagonist protocols on IVF/ICSI cycle outcome in group of patients considered “normal responder” and influence of luteal long GnRH agonist, microdose flare ...
Deniz Esinler +3 more
doaj
, 2023 ObjectiveTo compare the pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium.MethodsThis retrospective study included all fresh embryo transfers following GnRH agonist or GnRH ...
Xuemei Li (232384) +2 more
core +1 more source
Journal of Clinical Periodontology, EarlyView.ABSTRACT Objectives To identify local and systemic risk factors/indicators for dental biofilm‐induced gingivitis (DB‐GI) and to summarize evidence for their control. Methods A systematic review was undertaken following Preferred Reporting Items for Systematic Review and Meta‐Analyses (PRISMA) guidelines and divided into PECOTS and PICOTS questions ...
M. Gosset +6 more
wiley +1 more source
A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control
Case Reports in Oncology, 2019 GnRH antagonist and GnRH agonist are widely used as androgen deprivation therapy for metastatic prostate cancer. A previous report demonstrated that patients with PSA levels of >20 ng/mL using GnRH antagonists showed favorable outcomes in comparison
Rumiko Sugimura +5 more
doaj +1 more source
Down Regulation with Luteal GnRH Agonist Therapy in Euploid Embryo Transfers Does Not Impact Pregnancy Rates [PDF]
, 2020 Introduction : Gonadotropin-releasing hormone (GnRH) agonists have been used during assisted reproductive technology (ART) treatment for pituitary suppression and stimulation.
Levin, Isabelle +4 more
core
Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study [PDF]
, 2009 This study was designed to evaluate the effect of luteal-phase administration of single-dose gonadotrophin-releasing hormone (GnRH) agonist on pregnancy, implantation and live birth rates in patients who received GnRH antagonist for pituitary ...
Vicdan, Kubilay +13 more
core +1 more source
Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks
Experimental Physiology, EarlyView.Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan +4 more
wiley +1 more source